Search Results

Siramesine 10mg 10mg  | Purity Not Available

Adooq Bioscience

Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation.

More Information Supplier Page

AT 56 50mg 50mg  | Purity Not Available

Adooq Bioscience

AT-56 is am orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 ??M, IC50 = 95 ??M).

More Information Supplier Page

AT 56 5mg 5mg  | Purity Not Available

Adooq Bioscience

AT-56 is am orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 ??M, IC50 = 95 ??M).

More Information Supplier Page

AT 56 25mg 25mg  | Purity Not Available

Adooq Bioscience

AT-56 is am orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 ??M, IC50 = 95 ??M).

More Information Supplier Page

AT 56 10mg 10mg  | Purity Not Available

Adooq Bioscience

AT-56 is am orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 ??M, IC50 = 95 ??M).

More Information Supplier Page

Afuresertib 5mg 5mg  | Purity Not Available

Adooq Bioscience

Afuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. It binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of […]

More Information Supplier Page

PF-543 25mg 25mg  | Purity Not Available

Adooq Bioscience

PF-543 is a novel selective SK-1 inhibitor which inhibited SK-1 activity in a competitive manner with sphingosine.

More Information Supplier Page

NMS-1286937 25mg 25mg  | Purity Not Available

Adooq Bioscience

NMS-1286937 is an orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity.

More Information Supplier Page

NMS-1286937 10mg 10mg  | Purity Not Available

Adooq Bioscience

NMS-1286937 is an orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity.

More Information Supplier Page